ANDA 87361, held by Apothecon. Procainamide Hydrochloride.
As of Nov 21, 2026, ANDA 87361 (Pronestyl-Sr), held by Apothecon, was first approved by FDA on Aug 12, 1981, with 18 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 12, 1981 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Pronestyl-Sr500MG · tablet, extended release;oral | Procainamide Hydrochloride | Discontinued |
| Dec 29, 1997 | Supplement 24Manufacturing | Approved | None posted |
| Nov 9, 1993 | Supplement 23Manufacturing | Approved | None posted |
| May 28, 1993 | Supplement 20Manufacturing | Approved | None posted |
| Sep 17, 1991 | Supplement 22Labeling | Approved | None posted |
| May 2, 1991 | Supplement 21Labeling | Approved | None posted |
| Feb 26, 1990 | Supplement 19Bioequivalence | Approved | None posted |
| Feb 7, 1989 | Supplement 18Labeling | Approved | None posted |
| Dec 27, 1988 | Supplement 15Labeling | Approved | None posted |
| Dec 1, 1988 | Supplement 17Labeling | Approved | None posted |
| Aug 12, 1988 | Supplement 16Labeling | Approved | None posted |
| Feb 19, 1988 | Supplement 14Labeling | Approved | None posted |
| Jul 22, 1987 | Supplement 12Manufacturing | Approved | None posted |
| Jul 22, 1987 | Supplement 11Manufacturing | Approved | None posted |
| May 12, 1986 | Supplement 9Manufacturing | Approved | None posted |
| Jul 17, 1985 | Supplement 7Manufacturing | Approved | None posted |
| May 15, 1985 | Supplement 6Manufacturing | Approved | None posted |
| Jun 18, 1984 | Supplement 4Manufacturing | Approved | None posted |
| Nov 15, 1982 | Supplement 2Manufacturing | Approved | None posted |
| Aug 12, 1981 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters